Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.12B
| $1.22M | ﹤0.01% |
37,200
+5,200
| +16% | +$180K |
|
|
GLDG
2602
GoldMining Inc
GLDG
$226M
| $1.21M | ﹤0.01% |
710,475
+628,376
| +765% | +$1.05M |
|
2603
International Money Express
IMXI
$441M
| $1.21M | ﹤0.01% |
58,900
-33,500
| -36% | -$576K |
|
2604
NerdWallet
NRDS
$629M
| $1.21M | ﹤0.01% |
+101,200
| New | +$1.3M |
|
2605
NI Holdings
NODK
$312M
| $1.21M | ﹤0.01% |
71,491
-6,100
| -8% | -$109K |
|
2606
AquaBounty Technologies
AQB
$7.67M
| $1.21M | ﹤0.01% |
32,336
-15,041
| -32% | -$523K |
|
|
AUTO
2607
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $1.21M | ﹤0.01% |
521,911
-12,500
| -2% | -$33.4K |
|
|
ALLK
2608
DELISTED
Allakos
ALLK
| $1.21M | ﹤0.01% |
+211,400
| New | +$1.37M |
|
2609
Radiant Logistics
RLGT
$408M
| $1.2M | ﹤0.01% |
188,610
-44,590
| -19% | -$295K |
|
|
CDTX
2610
DELISTED
Cidara Therapeutics
CDTX
| $1.2M | ﹤0.01% |
71,892
+1,179
| +2% | +$20K |
|
2611
Vera Bradley
VRA
$93M
| $1.2M | ﹤0.01% |
156,100
-26,800
| -15% | -$212K |
|
|
NTP
2612
DELISTED
Nam Tai Property Inc.
NTP
| $1.2M | ﹤0.01% |
191,500
-145,841
| -43% | -$1.2M |
|
2613
McEwen Inc
MUX
$1.15B
| $1.2M | ﹤0.01% |
142,130
+115,220
| +428% | +$994K |
|
2614
TherapeuticsMD
TXMD
$24M
| $1.2M | ﹤0.01% |
62,952
+44,626
| +244% | +$702K |
|
|
ZYXI
2615
DELISTED
Zynex
ZYXI
| $1.2M | ﹤0.01% |
192,035
+106,501
| +125% | +$748K |
|
2616
Eterna Therapeutics
ERNA
$4.98M
| $1.19M | ﹤0.01% |
78
+38
| +95% | +$721K |
|
|
AFI
2617
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.19M | ﹤0.01% |
834,812
-31,718
| -4% | -$55.3K |
|
|
ZH
2618
Zhihu
ZH
$273M
| $1.19M | ﹤0.01% |
+81,967
| New | +$1.76M |
|
2619
Cipher Digital
CIFR
$7.41B
| $1.19M | ﹤0.01% |
+326,737
| New | +$1.05M |
|
2620
AGNC Investment
AGNC
$13B
| $1.19M | ﹤0.01% |
+90,629
| New | +$1.27M |
|
2621
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $1.19M | ﹤0.01% |
24,002
-11,338
| -32% | -$568K |
|
|
RTL
2622
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $1.18M | ﹤0.01% |
149,600
+73,500
| +97% | +$595K |
|
|
AWH
2623
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $1.18M | ﹤0.01% |
75,520
+11,805
| +19% | +$205K |
|
2624
iShares Global Financials ETF
IXG
$702M
| $1.18M | ﹤0.01% |
14,800
+2,900
| +24% | +$234K |
|
2625
Bio-Rad Laboratories Class B
BIO.B
| $1.18M | ﹤0.01% |
2,000
-200
| -9% | -$125K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.